Renata Ltd (RNTL)

Currency in BDT
494.00
+3.80(+0.78%)
Closed·
RNTL Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Unusual trading volume
Fair Value
Day's Range
491.40498.00
52 wk Range
470.10825.00
Key Statistics
Prev. Close
503.4
Open
492
Day's Range
491.4-498
52 wk Range
470.1-825
Volume
148.1K
Average Volume (3m)
14.49K
1-Year Change
-33.24%
Book Value / Share
302.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RNTL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
703.00
Upside
+42.31%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Renata Ltd Company Profile

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products. The company offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals. Its animal health products comprise antibiotic, cephalosporin, sulphonamides, anthelmintic, antiprotozoal, anti-histaminic, NSAID, glucocorticoid, appetizer and rumenotoric, and metabolic products, as well as vitamin-mineral and anti-fibrinolytic; and anthelmintic, anti-coccidial, anti-gout, electrolyte, nutritional premix, nutrition products, imported, and hormone products, as well as poultry and aqua products, and live and killed vaccines. In addition, the company provides oncology-based products; agro-based products; poultry products; and consumer products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993. Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Employees
7859

Compare RNTL to Peers and Sector

Metrics to compare
RNTL
Peers
Sector
Relationship
P/E Ratio
20.0x16.7x−0.5x
PEG Ratio
0.88−0.630.00
Price/Book
1.6x1.4x2.6x
Price / LTM Sales
1.4x2.5x3.2x
Upside (Analyst Target)
43.4%51.3%44.6%
Fair Value Upside
Unlock6.2%6.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 703.00
(+42.31% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 24.53%
Dividend Yield
1.86%
Annualized payout
9.20
Paid annually
5-Years Growth
+5.55%
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
5.74 / --
Revenue / Forecast
9.23B / --
EPS Revisions
Last 90 days

RNTL Income Statement

FAQ

What Is the Renata (RNTL) Stock Price Today?

The Renata stock price today is 494.00

What Stock Exchange Does Renata Trade On?

Renata is listed and trades on the Dhaka Stock Exchange stock exchange.

What Is the Stock Symbol for Renata?

The stock symbol for Renata is "RNTL."

Does Renata Pay Dividends? What’s The Current Dividend Yield?

The Renata dividend yield is 1.86%.

What Is the Renata Market Cap?

As of today, Renata market cap is 56.66B.

What Is Renata's Earnings Per Share (TTM)?

The Renata EPS (TTM) is 24.53.

When Is the Next Renata Earnings Date?

Renata will release its next earnings report on Sep 02, 2025.

From a Technical Analysis Perspective, Is RNTL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Renata Stock Split?

Renata has split 21 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.